Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)-Reference-Cited by-同舟云学术

Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)

Published:2012-12 Issue:3 Volume:78 Page:263-269
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Schnabel Philipp A.,Smit Egbert,Carpeo Javier de Castro,Leniewski-Kmak Krzysztof,Aerts Joachim,Kraaij Kees,Visseren-Grul Carla,Dyachkova Yulia,Taipale Kaisa,Girvan Allicia,Moro-Sibilot Denis

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO consensus Conference in Lung Cancer; Lugano 2010;Felip;Ann Oncol,2011

2. American society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer;Azzoli;J Clin Oncol,2009

3. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO clinical Practice Guidelines for diagnosis, treatment and follow-up;Crin?;Ann Oncol,2010

4. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes;Le Chevalier;Lung Cancer,2005

5. Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: A systematic review of randomized controlled trials

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Complementary Role of PET to Pathology in Differentiating the Primary Origin of a Malignant Skin Nodule from Liver or Lung;Nuclear Medicine and Molecular Imaging;2022-10-10

2. Comparison Between Health Insurance Claims and Electronic Health Records (EHRs) for Metastatic Non-small-cell Lung Cancer (NSCLC) Patient Characteristics and Treatment Patterns: A Retrospective Cohort Study;Drugs - Real World Outcomes;2021-08-28

3. Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life – A Case Study of the Innovative Medicines Initiative;Clinical Pharmacology & Therapeutics;2020-05-30

4. Molecular testing and treatment patterns for patients with advanced non-small cell lung cancer: PIvOTAL observational study;PLOS ONE;2018-08-27

5. Characteristics of Lung Cancer in Patients Younger than 40 Years: A Prospective Multicenter Analysis in France;Oncology;2018